Regulation of Survivin Isoform Expression by GLI Proteins in Ovarian Cancer
Tóm tắt
Ovarian cancer (OC) is the most lethal female gynecological malignancy, mostly due to diagnosis in late stages when treatment options are limited. Hedgehog-GLI (HH-GLI) signaling is a major developmental pathway involved in organogenesis and stem cell maintenance, and is activated in OC. One of its targets is survivin (BIRC5), an inhibitor of apoptosis protein (IAP) that plays a role in multiple processes, including proliferation and cell survival. We wanted to investigate the role of different GLI proteins in the regulation of survivin isoform expression (WT, 2α, 2B, 3B, and Δex3) in the SKOV-3 OC cell line. We demonstrated that survivin isoforms are downregulated in GLI1 and GLI2 knock-out cell lines, but not in the GLI3 knock-out. Treatment of GLI1 knock-out cells with GANT-61 shows an additional inhibitory effect on several isoforms. Additionally, we examined the expression of survivin isoforms in OC samples and the potential role of BIRC5 polymorphisms in isoform expression. Clinical samples showed the same pattern of survivin isoform expression as in the cell line, and several BIRC5 polymorphisms showed the correlation with isoform expression. Our results showed that survivin isoforms are regulated both by different GLI proteins and BIRC5 polymorphisms in OC.
Từ khóa
Tài liệu tham khảo
Bell, 2005, Shh signaling in limb bud ectoderm: Potential role in teratogen-induced postaxial ectrodactyly, Dev. Dyn., 233, 313, 10.1002/dvdy.20409
Sabol, M., Trnski, D., Musani, V., Ozretić, P., and Levanat, S. (2018). Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets. Int. J. Mol. Sci., 19.
Sabol, 2012, The Hedgehog signaling pathway in ovarian teratoma is stimulated by Sonic Hedgehog which induces internalization of Patched, Int. J. Oncol., 41, 1411, 10.3892/ijo.2012.1554
Vachtenheim, 2016, Survivin, a novel target of the Hedgehog/GLI signaling pathway in human tumor cells, Cell Death Dis., 7, e2048, 10.1038/cddis.2015.389
Brun, 2015, Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma, Oncogene, 34, 3770, 10.1038/onc.2014.304
Altieri, 2003, Validating survivin as a cancer therapeutic target, Nat. Rev. Cancer, 3, 46, 10.1038/nrc968
Han, 2009, Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancer, Int. J. Clin. Exp. Med., 2, 289
Antonacopoulou, 2010, The survivin -31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival, Anal. Cell Pathol., 33, 177, 10.1155/2010/673592
Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med., 3, 917, 10.1038/nm0897-917
Caldas, 2005, Survivin 2α: A novel Survivin splice variant expressed in human malignancies, Mol. Cancer, 4, 11, 10.1186/1476-4598-4-11
Boidot, 2009, Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy, Int. J. Mol. Med., 23, 285
Ghaffari, 2017, Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α, Asia Pac. J. Clin. Oncol., 13, e21
Mahotka, 1999, Survivin-deltaEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties, Cancer Res., 59, 6097
Krieg, 2002, Expression of different survivin variants in gastric carcinomas: First clues to a role of survivin-2B in tumour progression, Br. J. Cancer, 86, 737, 10.1038/sj.bjc.6600153
Ling, 2007, Forced expression of survivin-2B abrogates mitotic cells and induces mitochondria-dependent apoptosis by blockade of tubulin polymerization and modulation of Bcl-2, Bax, and survivin, J. Biol. Chem., 282, 27204, 10.1074/jbc.M705161200
Cho, 2011, Expression of the survivin-2B splice variant related to the progression of colorectal carcinoma, J. Korean Surg. Soc., 80, 404, 10.4174/jkss.2011.80.6.404
Shi, 2014, Survivin-2B promotes autophagy by accumulating IKK alpha in the nucleus of selenite-treated NB4 cells, Cell Death Dis., 5, e1071, 10.1038/cddis.2014.34
Han, 2011, Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer, Clin. Cancer Res., 17, 3716, 10.1158/1078-0432.CCR-11-0233
Badran, 2004, Identification of a novel splice variant of the human anti-apoptopsis gene survivin, Biochem. Biophys. Res. Commun., 314, 902, 10.1016/j.bbrc.2003.12.178
Knauer, 2007, The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein, Cell Cycle, 6, 1502, 10.4161/cc.6.12.4305
Sawai, 2010, Survivin-3B gene decreases the invasion-inhibitory effect of colon cancer cells with 5-fluorouracil, Oncol. Res., 18, 541, 10.3727/096504010X12767359113848
Boidot, 2011, Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma, Endocr. Relat. Cancer, 18, 783, 10.1530/ERC-11-0105
Mahotka, 2002, Differential subcellular localization of functionally divergent survivin splice variants, Cell Death Differ., 9, 1334, 10.1038/sj.cdd.4401091
Lopergolo, 2012, Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer, Cancer Res., 72, 3251, 10.1158/0008-5472.CAN-11-4035
Vandghanooni, 2011, Survivin-deltaEx3: A novel biomarker for diagnosis of papillary thyroid carcinoma, J. Cancer Res. Ther., 7, 325, 10.4103/0973-1482.87038
Altieri, 2006, Targeted therapy by disabling crossroad signaling networks: The survivin paradigm, Mol. Cancer Ther., 5, 478, 10.1158/1535-7163.MCT-05-0436
Stobiecka, 2016, Piezometric biosensors for anti-apoptotic protein survivin based on buried positive-potential barrier and immobilized monoclonal antibodies, Biosens. Bioelectron., 84, 37, 10.1016/j.bios.2015.10.041
Ratajczak, K., Krazinski, B.E., Kowalczyk, A.E., Dworakowska, B., Jakiela, S., and Stobiecka, M. (2018). Optical Biosensing System for the Detection of Survivin mRNA in Colorectal Cancer Cells Using a Graphene Oxide Carrier-Bound Oligonucleotide Molecular Beacon. Nanomaterials, 8.
Jang, 2008, Polymorphisms in the survivin gene and the risk of lung cancer, Lung Cancer, 60, 31, 10.1016/j.lungcan.2007.09.008
Cheng, 2008, [Correlation of -31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma], Ai Zheng, 27, 258
Kawata, 2011, Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility, Int. J. Cancer, 129, 1872, 10.1002/ijc.25850
Weng, 2012, Survivin SNP-carcinogen interactions in oral cancer, J. Dent. Res., 91, 358, 10.1177/0022034512438402
Hsieh, 2012, Survivin T9809C, an SNP located in 3’-UTR, displays a correlation with the risk and clinicopathological development of hepatocellular carcinoma, Ann. Surg. Oncol., 19, S625, 10.1245/s10434-011-2123-3
Shi, 2012, Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer, Breast Cancer Res. Treat., 131, 1039, 10.1007/s10549-011-1826-2
Cong, 2013, Multiplex Genome Engineering Using CRISPR/Cas Systems, Science, 339, 819, 10.1126/science.1231143
Trnski, 2017, Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas, Int. J. Oncol., 51, 1869, 10.3892/ijo.2017.4156
Hofstetter, 2010, Alternative splicing of p53 and p73: The novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer, Oncogene, 29, 1997, 10.1038/onc.2009.482
Untergasser, 2012, Primer3--new capabilities and interfaces, Nucleic Acids Res., 40, e115, 10.1093/nar/gks596
Cvok, 2008, New sequence variants in BRCA1 and BRCA2 genes detected by high-resolution melting analysis in an elderly healthy female population in Croatia, Clin. Chem. Lab. Med., 46, 1376, 10.1515/CCLM.2008.307
Roessler, 2005, A previously unidentified amino-terminal domain regulates transcriptional activity of wild-type and disease-associated human GLI2, Hum. Mol. Genet., 14, 2181, 10.1093/hmg/ddi222
Dai, 2010, Prognostic significance of survivin polymorphisms on non-small cell lung cancer survival, J. Thorac. Oncol., 5, 1748, 10.1097/JTO.0b013e3181f18cb9
Aynaci, 2013, Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer, Genet. Mol. Res., 12, 3975, 10.4238/2013.February.28.9
Yang, 2009, Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma, J. Cancer Res. Clin. Oncol., 135, 1341, 10.1007/s00432-009-0575-7
Hmeljak, 2011, BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients, J. Cancer Res. Clin. Oncol., 137, 1641, 10.1007/s00432-011-1030-0
Boidot, 2008, The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas, Genes Chromosomes Cancer, 47, 299, 10.1002/gcc.20533
Pu, 2015, Association between functional variants in BIRC5/survivin gene 3’ untranslated region and mRNA expression in lymphoblastoid cell lines, Oncol. Lett., 10, 2319, 10.3892/ol.2015.3507
Li, 2013, Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population, DNA Cell Biol., 32, 236, 10.1089/dna.2012.1912
Rosato, 2013, Survivin expression impacts prognostically on NSCLC but not SCLC, Lung Cancer, 79, 180, 10.1016/j.lungcan.2012.11.004
Kafadar, 2018, Investigation of Survivin Gene Polymorphism and Serum Survivin Levels in Patients with Brain Tumors, Anticancer Res., 38, 5991, 10.21873/anticanres.12947